Fyarro

Active Ingredient(s): Sirolimus Albumin-Bound Nanoparticles
FDA Approved: * November 22, 2021
Pharm Company: * AADI BIOSCIENCE INC
Category: Cancer

Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumor (PEComa).[1][2][8][9] It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants.... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Fyarro 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Suspension
NDC: 80803-153
Labeler:
Aadi Bioscience

Related Brands

Drugs with the same active ingredients